Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Investing Activities (2023 - 2025)

Upstream Bio (UPB) has 3 years of Cash from Investing Activities data on record, last reported at $48.2 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 3319.87% year-over-year to $48.2 million; the TTM value through Sep 2025 reached -$110.5 million, down 3.64%, while the annual FY2024 figure was -$59.5 million, 28.19% up from the prior year.
  • Cash from Investing Activities reached $48.2 million in Q3 2025 per UPB's latest filing, up from $12.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $48.2 million in Q3 2025 and bottomed at -$213.4 million in Q1 2025.
  • Average Cash from Investing Activities over 3 years is -$27.1 million, with a median of $7.1 million recorded in 2024.
  • The widest YoY moves for Cash from Investing Activities: up 3319.87% in 2025, down 1640.43% in 2025.
  • A 3-year view of Cash from Investing Activities shows it stood at -$5.2 million in 2023, then soared by 899.47% to $41.9 million in 2024, then increased by 14.98% to $48.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $48.2 million in Q3 2025, $12.8 million in Q2 2025, and -$213.4 million in Q1 2025.